Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Appointed director
Quarterly results
Mirati Therapeutics, Inc. (MRTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
10/11/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
10/10/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
10/10/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/06/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/15/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/16/2021 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/17/2020 DEF 14A Form DEF 14A - Other definitive proxy statements:
05/02/2019 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/19/2019 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/20/2018 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/20/2017 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/19/2016 DEF 14A Form DEF 14A - Other definitive proxy statements
04/23/2015 DEF 14A Form DEF 14A - Other definitive proxy statements
04/17/2014 DEF 14A Form DEF 14A - Other definitive proxy statements

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy